Immunizations services, convenience packaging, and more!
COVID-19 Had Worst Disease Outcomes Among Respiratory Viruses
In their exploration of 2 separate respiratory virus seasons, researchers examined the severity of illness for SARS-CoV-2, influenza, and respiratory syncytial virus.
Looking to the Future of Independent Pharmacy
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Vaccine Hesitancy, Access Growing Concerns Among Patients With Chronic Diseases
A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.
Easing The Burden of Burnout With Technology
Lani Bertrand, RPh, joins the latest episode of Over The Counter to discuss the role of technology in easing burnout during the COVID-19 pandemic.
ACIP Publishes Final Pneumococcal Vaccine Recommendations
These recommendations were voted on at the October 2024 Advisory Committee on Immunization Practices meeting.
FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
Patients who receive either Pfizer or GSK’s respiratory syncytial virus vaccine may be at increased risk of Guillain-Barré syndrome.